Clinical trial
Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1
NCT05927285 is registered in ClinicalTrials.gov with Hospital Civil de Guadalajara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1
- Lead sponsor
- Hospital Civil de Guadalajara
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 20, 2022
- Completion date
- February 26, 2023
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, cardiorenal syndrome, decompensated heart failure, fluid overload, ultrasound therapy; complications